Evidence map›Paper›PMID 33603657›Full record

ArticleFrontiers in aging neuroscience2021

Detection Gap of Right-Asymmetric Neuronal Degeneration by CERAD Test Battery in Alzheimer's Disease.

Annika Kreuzer, Julia Sauerbeck, Maximilian Scheifele, Anna Stockbauer, Sonja Schönecker, Catharina Prix, Elisabeth Wlasich, Sandra V Loosli, Philipp M Kazmierczak, Marcus Unterrainer and 14 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in aging neuroscience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 4 institutions in 3 countries.

Annika KreuzerDepartment of Nuclear Medicine, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.
Julia SauerbeckDepartment of Nuclear Medicine, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.
Maximilian ScheifeleDepartment of Nuclear Medicine, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.
Anna StockbauerDepartment of Nuclear Medicine, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.
Sonja SchöneckerDepartment of Neurology, University Hospital, Ludwig-Maximilians-University, Munich, Germany.
Catharina PrixDepartment of Neurology, University Hospital, Ludwig-Maximilians-University, Munich, Germany.
Elisabeth WlasichDepartment of Neurology, University Hospital, Ludwig-Maximilians-University, Munich, Germany.
Sandra V LoosliDepartment of Neurology, University Hospital, Ludwig-Maximilians-University, Munich, Germany.
Philipp M KazmierczakDepartment of Radiology, University Hospital, Ludwig-Maximilians-University, Munich, Germany.
Marcus UnterrainerDepartment of Nuclear Medicine, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.
Cihan CatakInstitute for Stroke and Dementia Research, University Hospital, Ludwig-Maximilians-University, Munich, Germany.
Daniel JanowitzInstitute for Stroke and Dementia Research, University Hospital, Ludwig-Maximilians-University, Munich, Germany.
Oliver PogarellDepartment of Psychiatry, University Hospital, Ludwig-Maximilians-University, Munich, Germany.
Carla PalleisDepartment of Neurology, University Hospital, Ludwig-Maximilians-University, Munich, Germany.
Robert PerneczkyDepartment of Psychiatry, University Hospital, Ludwig-Maximilians-University, Munich, Germany.
Nathalie L AlbertDepartment of Nuclear Medicine, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.
Peter BartensteinDepartment of Nuclear Medicine, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.
Adrian DanekDepartment of Neurology, University Hospital, Ludwig-Maximilians-University, Munich, Germany.
Katharina BuergerInstitute for Stroke and Dementia Research, University Hospital, Ludwig-Maximilians-University, Munich, Germany.
Johannes LevinDepartment of Neurology, University Hospital, Ludwig-Maximilians-University, Munich, Germany.
Andreas ZwergalDepartment of Neurology, University Hospital, Ludwig-Maximilians-University, Munich, Germany.
Axel RomingerDepartment of Nuclear Medicine, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.
Matthias BrendelDepartment of Nuclear Medicine, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.
Leonie BeyerDepartment of Nuclear Medicine, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.
Ludwig-Maximilians-Universität München · DEGerman Center for Neurodegenerative Diseases · DEMunich Cluster for Systems Neurology · DEUniversity Hospital of Bern · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Alzheimer’s diseaseasymmetrycognitive performanceFDG-PEThippocampal atrophy

Identifiers

PMID33603657
PMCPMC7884314
OpenAlexW3126783091

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.